Skip to main content

Hyperfine, Inc.

HYPR
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001833769

In the last 90 days, Hyperfine, Inc. insiders filed 0 open-market purchases and 2 sales; 80 institutions reported holding it in 13F filings for Q2 2026, worth $29.4M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Hyperfine, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of HYPR: Q4 2022 compared with Q1 2023
MeasureQ4 2022Of which not filed for Q1 2023Q1 2023Change
Holders39134−4
Shares15.4M3.88M9.24M−2.24M (−19.5%)
Value$12.9M$3.26M$13.2M+$3.55M (+37.0%)

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Hyperfine, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to HYPR in Q1 2023
InstitutionSharesValue% of portfolio
Two Sigma Investments, LP88,592$127.6K0.00%
Global Retirement Partners, LLC1,500$2.10K0.00%
Royal Bank of Canada448$1.00K0.00%
Cape Investment Advisory, Inc.200$2880.00%

Sold out (8)

Institutions that held Hyperfine, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of HYPR in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Jefferies Financial Group Inc.300,000$252.0K
APG Asset Management N.V.104,946$88.0K
Susquehanna International Group, LLP31,070$26.1K
Renaissance Technologies LLC17,500$15.0K
CWM, LLC10,000$8.00K
Morgan Stanley2,392$2.01K
Rockefeller Capital Management L.P.3,000$2.00K
Rossmore Private Capital41,325$0

Not filed for Q1 2023 yet (1)

Institutions that held Hyperfine, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HYPR in Q4 2022 that haven't filed for Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
HealthCor Management, L.P.3,880,900$3.26M